Skip Navigation

Study in Nigeria finds 1 in 10 malaria drugs are poor quality

Substandard medicines are more prevalent than fakes in the world’s most malaria-burdened country, according to new research published in PLOS ONE.

Get the new Roll Back Malaria (RBM) App!

RBM app is now available, which is a comprehensive interactive resource that directly connect readers with the latest RBM news feeds and provides users with up to the minutes information on its activities.

Videos and more

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

Malaria research publications

Browse through more than 80 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.